Next Article in Journal
Cancer Biomarkers: Are We Ready for the Prime Time?
Next Article in Special Issue
Automated Dermoscopy Image Analysis of Pigmented Skin Lesions
Previous Article in Journal
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
Previous Article in Special Issue
Angiogenesis and Melanoma
Cancers 2010, 2(1), 165-189; doi:10.3390/cancers2010165

Biology of Human Cutaneous Melanoma

* ,
Received: 28 January 2010 / Revised: 4 March 2010 / Accepted: 9 March 2010 / Published: 12 March 2010
View Full-Text   |   Download PDF [417 KB, uploaded 14 March 2010]   |   Browse Figures
Abstract: A review of the natural behavior of cutaneous melanoma, clinical and pathological factors, prognostic indicators, some basic research and the present and possible futuristic strategies in the management of this disease are presented. While surgery remains to be the most effective therapeutic approach in the management of early primary lesions, there is no standard adjuvant therapy after surgical resection, or for metastatic disease.
Keywords: biology; cutaneous; melanoma; therapeutic approaches biology; cutaneous; melanoma; therapeutic approaches
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Elias, E.G.; Hasskamp, J.H.; Sharma, B.K. Biology of Human Cutaneous Melanoma. Cancers 2010, 2, 165-189.

AMA Style

Elias EG, Hasskamp JH, Sharma BK. Biology of Human Cutaneous Melanoma. Cancers. 2010; 2(1):165-189.

Chicago/Turabian Style

Elias, Elias G.; Hasskamp, Joanne H.; Sharma, Bhuvnesh K. 2010. "Biology of Human Cutaneous Melanoma." Cancers 2, no. 1: 165-189.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert